Gencor Industries Inc
GENC NYSE Construction Machinery & Equip Financials FY2016βFY2025
What Gencor Industries Inc does
No business description yet.
- Legal name
- GENCOR INDUSTRIES INC
- Fiscal year ends
- September 30, 2025
- Latest annual report
- 10-K Β· Dec 9, 2025
- Accession Β· CIK
- 0001193125-25-312742
0000064472
Revenue and margins
Gencor Industries Inc had $115M of revenue in fiscal 2025, up 2.0% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 9.3% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.1M in fiscal 2025, 1.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Gencor Industries Inc returned β to shareholders in fiscal 2025. The diluted share count rose 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Gencor Industries Inc can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $118M | $98.9M | $101M | $115M | $136M |
| Debt incl. finance leases | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Net debt / EBITDA | β35.9x | β14.1x | β6.2x | β7.1x | β8.3x |
| Debt / equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Current ratio | 14.7x | 13.1x | 12.6x | 18.2x | 23.4x |
| Quick ratio | 11.0x | 8.6x | 7.6x | 12.2x | 17.4x |
| Total assets | $179M | $179M | $196M | $208M | $223M |
| Total liabilities | $12.2M | $12.4M | $14.3M | $12.0M | $10.8M |
| Shareholders' equity | $167M | $167M | $182M | $196M | $212M |
| Net debt (β = net cash) | β$118M | β$98.9M | β$101M | β$115M | β$136M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 5 / 9 | 5 / 9 | 5 / 9 | 3 / 9 | 4 / 9 | 2 / 9 | 5 / 9 | 5 / 8 | 4 / 8 |
| Accruals ratio | 0.0% | 1.7% | 16.5% | 3.8% | β12.6% | 1.1% | 4.9% | 2.4% | 2.6% | 5.8% |
| Altman Z'' | 23.85 | 18.55 | 22.90 | 25.72 | 26.05 | 22.92 | 22.56 | 22.06 | 26.23 | 29.75 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $70.0M | $80.6M | $98.6M | $81.3M | $77.4M | $85.3M | $103M | $105M | $113M | $115M |
| Gross profit | $17.5M | $21.2M | $26.8M | $22.4M | $19.0M | $18.2M | $20.5M | $29.0M | $31.3M | $31.7M |
| Research and development | $1.6M | $2.1M | $2.9M | $3.3M | $3.1M | $4.3M | $4.3M | $3.5M | $3.3M | $2.8M |
| Operating income | $7.8M | $10.2M | $13.9M | $9.5M | $5.5M | $0.7M | $4.2M | $13.4M | $13.7M | $14.0M |
| Pretax income | $9.4M | $12.2M | $15.1M | $12.8M | $6.7M | $6.6M | β$1.7M | $18.8M | $20.7M | $20.2M |
| Income tax | $2.4M | $3.8M | $2.4M | $2.6M | $1.2M | $0.8M | β$1.3M | $4.1M | $6.2M | $4.5M |
| Net income | $7.0M | $8.4M | $12.7M | $10.2M | $5.5M | $5.8M | β$0.4M | $14.7M | $14.6M | $15.7M |
| Diluted EPS | $0.48 | $0.57 | $0.86 | $0.69 | $0.38 | $0.39 | β$0.03 | $1.00 | $0.99 | $1.07 |
| Diluted shares | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | β | β |
| Cash flow | ||||||||||
| Cash from operations | $7.0M | $6.1M | β$12.0M | $4.2M | $26.8M | $3.8M | β$9.1M | $10.2M | $9.3M | $3.1M |
| Capital expenditure | $0.3M | $1.6M | $3.6M | $2.1M | $1.6M | $2.7M | $4.5M | $2.7M | $0.8M | $2.0M |
| Free cash flow | $6.7M | $4.5M | β$15.5M | $2.1M | $25.2M | $1.2M | β$13.7M | $7.5M | $8.5M | $1.1M |
| Depreciation and amortization | $1.4M | $1.1M | $1.4M | $1.6M | $1.6M | $2.6M | $2.8M | $2.8M | $2.6M | $2.4M |
| Stock-based compensation | $0.0M | $0.1M | $0.1M | $0.1M | $0.1M | β | β | β | β | β |
| Acquisitions | β | β | β | β | β | $13.8M | β | β | β | β |
| Balance sheet | ||||||||||
| Cash and short-term investments | $104M | $111M | $112M | $116M | $125M | $118M | $98.9M | $101M | $115M | $136M |
| Total debt | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $123M | $137M | $148M | $157M | $162M | $167M | $162M | $179M | $193M | $207M |
| Current liabilities | $8.2M | $12.4M | $8.5M | $6.5M | $8.5M | $11.4M | $12.4M | $14.2M | $10.6M | $8.8M |
| Inventory | $11.6M | $16.7M | $21.9M | $25.4M | $27.1M | $41.9M | $55.8M | $71.5M | $63.8M | $53.5M |
| Property and equipment, net | $5.2M | $5.7M | $7.9M | $8.4M | $8.3M | $11.8M | $13.5M | $13.2M | $11.5M | $11.1M |
| Total assets | $129M | $143M | $156M | $165M | $171M | $179M | $179M | $196M | $208M | $223M |
| Total liabilities | $8.5M | $14.0M | $11.1M | $9.9M | $9.9M | $12.2M | $12.4M | $14.3M | $12.0M | $10.8M |
| Preferred stock | β | β | β | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $120M | $129M | $145M | $156M | $161M | $167M | $167M | $182M | $196M | $212M |
| Margins | ||||||||||
| Gross margin | 25.0% | 26.2% | 27.2% | 27.6% | 24.5% | 21.3% | 19.9% | 27.6% | 27.7% | 27.5% |
| Operating margin | 11.2% | 12.7% | 14.1% | 11.6% | 7.2% | 0.8% | 4.0% | 12.8% | 12.1% | 12.1% |
| EBITDA margin | 13.2% | 14.1% | 15.5% | 13.6% | 9.3% | 3.9% | 6.8% | 15.5% | 14.4% | 14.2% |
| Net margin | 10.1% | 10.4% | 12.9% | 12.5% | 7.1% | 6.8% | β0.4% | 14.0% | 12.9% | 13.6% |
| FCF margin | 9.6% | 5.6% | β15.8% | 2.5% | 32.5% | 1.4% | β13.2% | 7.1% | 7.5% | 1.0% |
| Returns | ||||||||||
| Return on capital | 36.5% | 39.1% | 35.5% | 18.9% | 12.7% | 1.2% | 4.8% | 13.1% | 11.9% | 14.4% |
| Return on capital employed | 6.5% | 7.8% | 9.4% | 6.0% | 3.4% | 0.4% | 2.5% | 7.4% | 6.9% | 6.6% |
| Return on equity | 5.9% | 6.8% | 9.3% | 6.8% | 3.5% | 3.5% | β0.2% | 8.4% | 7.7% | 7.7% |
| Return on assets | 5.5% | 6.2% | 8.5% | 6.3% | 3.3% | 3.3% | β0.2% | 7.8% | 7.2% | 7.3% |
| Return on tangible equity | 5.9% | 6.5% | 8.8% | 6.6% | 3.4% | 3.5% | β0.2% | 8.1% | 7.4% | 7.4% |
| Growth | ||||||||||
| Revenue growth | β | 15.2% | 22.3% | β17.5% | β4.8% | 10.1% | 21.3% | 1.5% | 7.7% | 2.0% |
| Net income growth | β | 19.5% | 50.8% | β19.7% | β45.8% | 5.0% | β106.4% | β | β0.7% | 7.6% |
| EPS growth | β | 18.8% | 50.9% | β19.8% | β44.9% | 2.6% | β107.7% | β | β1.0% | 8.1% |
| FCF growth | β | β32.9% | β446.7% | β | 1,122.9% | β95.4% | β1,275.8% | β | 13.4% | β86.9% |
| Share count change | β | 1.1% | 0.3% | β0.1% | 0.1% | 0.1% | β0.5% | 0.0% | β | β |
| Financial health | ||||||||||
| Net debt / EBITDA | β11.3x | β9.8x | β7.3x | β10.4x | β17.4x | β35.9x | β14.1x | β6.2x | β7.1x | β8.3x |
| Debt / equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Current ratio | 15.1x | 11.1x | 17.5x | 24.2x | 19.0x | 14.7x | 13.1x | 12.6x | 18.2x | 23.4x |
| Quick ratio | 13.6x | 9.7x | 14.9x | 20.3x | 15.8x | 11.0x | 8.6x | 7.6x | 12.2x | 17.4x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.4% | 2.0% | 3.6% | 2.6% | 2.1% | 3.1% | 4.4% | 2.6% | 0.7% | 1.7% |
| Stock comp / revenue | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | β | β | β | β | β |
| Quality scores | ||||||||||
| Piotroski F-score | β | 5.0 | 5.0 | 5.0 | 3.0 | 4.0 | 2.0 | 5.0 | 5.0 | 4.0 |
| Altman Z'' | 23.8 | 18.5 | 22.9 | 25.7 | 26.0 | 22.9 | 22.6 | 22.1 | 26.2 | 29.7 |
| Accruals ratio | 0.0% | 1.7% | 16.5% | 3.8% | β12.6% | 1.1% | 4.9% | 2.4% | 2.6% | 5.8% |
Source: SEC EDGAR XBRL filings (CIK 0000064472). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.